DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - INTERCEPT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAD0. A total of 1 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Links
Filings
Quarter-by-quarter ownership
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$31,845,000
-0.7%
29,595,0000.0%0.41%
-13.3%
Q4 2021$32,055,000
+112.3%
29,595,000
+97.3%
0.47%
+118.5%
Q3 2021$15,097,000–15,000,000–0.22%–
 Download
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 29,595,000$32,055,0000.47%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders